Review

Published on 26 Sep 2022

The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development

in Molecular and Cellular Oncology

Shougeng Liu
Sihong Chen
Chengfang Tang
Yingxi Zhao
Wei Cui
Lina Jia
Lihui Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.970833

2,461 views
2 citations

Original Research

Published on 26 Sep 2022

IL-6, TNF-α and IL-12p70 levels in patients with colorectal cancer and their predictive value in anti-vascular therapy

in Molecular and Cellular Oncology

Jingxian Zheng
Xiaojie Wang
Jiami Yu
Zhouwei Zhan
Zengqing Guo

Frontiers in Oncology

doi 10.3389/fonc.2022.997665

2,462 views
7 citations

Correction

Published on 23 Sep 2022

Corrigendum: Somatic DNA damage response and homologous repair gene alterations and its association with tumor variant burden in breast cancer patients with occupational exposure to pesticides

in Molecular and Cellular Oncology

Thalita Basso Scandolara
Sara Ferreira Valle
Cristiane Esteves
Nicole de Miranda Scherer
Elvismary M. de Armas
Carolina Furtado
Renan Gomes
Mariana Boroni
Hellen dos Santos Jaques
Fernanda Mara Alves

Frontiers in Oncology

doi 10.3389/fonc.2022.1014392

887 views

Original Research

Published on 23 Sep 2022

LncRNA SNHG6 sponges miR-101 and induces tamoxifen resistance in breast cancer cells through induction of EMT

in Molecular and Cellular Oncology

Mohammad Imran Khan
Aamir Ahmad

Frontiers in Oncology

doi 10.3389/fonc.2022.1015428

2,405 views
11 citations

Original Research

Published on 23 Sep 2022

CDK7 is a prognostic biomarker for non-small cell lung cancer

in Molecular and Cellular Oncology

Christiane Kuempers
Tobias Jagomast
Carsten Heidel
Finn-Ole Paulsen
Sabine Bohnet
Stefanie Schierholz
Eva Dreyer
Jutta Kirfel
Sven Perner

Frontiers in Oncology

doi 10.3389/fonc.2022.927140

2,312 views
1 citation

Mini Review

Published on 23 Sep 2022

Metabolite-derived protein modifications modulating oncogenic signaling

in Molecular and Cellular Oncology

Yawen Liu
Anke Vandekeere
Min Xu
Sarah-Maria Fendt
Patricia Altea-Manzano

Frontiers in Oncology

doi 10.3389/fonc.2022.988626

4,793 views
2 citations

Original Research

Published on 23 Sep 2022

Comprehensive analysis of the prognostic signature and tumor microenvironment infiltration characteristics of cuproptosis-related lncRNAs for patients with colon adenocarcinoma

in Molecular and Cellular Oncology

Guoliang Cui
Jinhui Liu
Can Wang
Renjun Gu
Manli Wang
Zhiguang Sun
Fei Wei

Frontiers in Oncology

doi 10.3389/fonc.2022.1007918

4,132 views
10 citations

Systematic Review

Published on 23 Sep 2022

Thyroid and renal cancers: A bidirectional association

in Molecular and Cellular Oncology

Maria Irene Bellini
Eleonora Lori
Flavio Forte
Augusto Lauro
Domenico Tripodi
Maria Ida Amabile
Vito Cantisani
Marzia Varanese
Iulia Catalina Ferent
Enke Baldini

Frontiers in Oncology

doi 10.3389/fonc.2022.951976

8,167 views
16 citations

Review

Published on 23 Sep 2022

MET alterations in advanced pulmonary sarcomatoid carcinoma

in Molecular and Cellular Oncology

Chen Gong
Huihua Xiong
Kai Qin
Jianhua Wang
Yi Cheng
Jing Zhao
Jing Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1017026

3,465 views
15 citations

Original Research

Published on 23 Sep 2022

Construction and validation of a prognostic model with RNA binding protein-related mRNAs for the HBV-related hepatocellular carcinoma patients

in Molecular and Cellular Oncology

Shaohua Xu
Hui Liu
Renyun Tian
Jiahui Xie
Su Chen
Junyun Luo
Haizhen Zhu
Yirong Wang
Zhaoyong Li

Frontiers in Oncology

doi 10.3389/fonc.2022.970613

1,757 views
1 citation

Mini Review

Published on 23 Sep 2022

Role of hypoxia in the tumor microenvironment and targeted therapy

in Molecular and Cellular Oncology

Gaoqi Chen
Kaiwen Wu
Hao Li
Demeng Xia
Tianlin He

Frontiers in Oncology

doi 10.3389/fonc.2022.961637

7,147 views
41 citations

Review

Published on 21 Sep 2022

Aquaporins: New players in breast cancer progression and treatment response

in Molecular and Cellular Oncology

Verodia Charlestin
Daniel Fulkerson
Carlos E. Arias Matus
Zachary T. Walker
Kevin Carthy
Laurie E. Littlepage

Frontiers in Oncology

doi 10.3389/fonc.2022.988119

5,021 views
19 citations

Original Research

Published on 21 Sep 2022

A major role for Nrf2 transcription factors in cell transformation by KSHV encoded oncogenes

in Molecular and Cellular Oncology

Daiana Sapochnik
Ana R. Raimondi
Victoria Medina
Julian Naipauer
Enrique A. Mesri
Omar Coso

Frontiers in Oncology

doi 10.3389/fonc.2022.890825

2,083 views
2 citations

Editorial

Published on 21 Sep 2022

Editorial: The role of iron in cancer progression

in Molecular and Cellular Oncology

Ahmed Hamaï
Chang Gong
Maryam Mehrpour

Frontiers in Oncology

doi 10.3389/fonc.2022.1026420

1,588 views
1 citation

Original Research

Published on 21 Sep 2022

LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer

in Molecular and Cellular Oncology

Zhengwei Song
Xiaoguang Wang
Fei Chen
Qiuli Chen
Wenjun Liu
Xiaodan Yang
Xun Zhu
Xiaorong Liu
Peter Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1004212

3,856 views
32 citations

Original Research

Published on 21 Sep 2022

A distinct subpopulation of leukemia initiating cells in acute precursor B lymphoblastic leukemia: quiescent phenotype and unique transcriptomic profile

in Molecular and Cellular Oncology

Alex Q. Lee
Hiroaki Konishi
Connie Duong
Sakiko Yoshida
Ryan R. Davis
Jonathan E. Van Dyke
Masami Ijiri
Bridget McLaughlin
Kyoungmi Kim
Yueju Li

Frontiers in Oncology

doi 10.3389/fonc.2022.972323

2,934 views
1 citation

Navigation group

Articles

The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development

IL-6, TNF-α and IL-12p70 levels in patients with colorectal cancer and their predictive value in anti-vascular therapy

Corrigendum: Somatic DNA damage response and homologous repair gene alterations and its association with tumor variant burden in breast cancer patients with occupational exposure to pesticides

LncRNA SNHG6 sponges miR-101 and induces tamoxifen resistance in breast cancer cells through induction of EMT

CDK7 is a prognostic biomarker for non-small cell lung cancer

Metabolite-derived protein modifications modulating oncogenic signaling

Comprehensive analysis of the prognostic signature and tumor microenvironment infiltration characteristics of cuproptosis-related lncRNAs for patients with colon adenocarcinoma

Thyroid and renal cancers: A bidirectional association

MET alterations in advanced pulmonary sarcomatoid carcinoma

Construction and validation of a prognostic model with RNA binding protein-related mRNAs for the HBV-related hepatocellular carcinoma patients

Role of hypoxia in the tumor microenvironment and targeted therapy

Aquaporins: New players in breast cancer progression and treatment response

A major role for Nrf2 transcription factors in cell transformation by KSHV encoded oncogenes

Editorial: The role of iron in cancer progression

LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer

A distinct subpopulation of leukemia initiating cells in acute precursor B lymphoblastic leukemia: quiescent phenotype and unique transcriptomic profile